Reber, U <br/><br/>
Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.  [electronic resource] 

 -  Biochemical pharmacology  Feb 1998 
 - 349-59 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-2952 
<br/><br/><label>Standard No.: </label>10.1016/s0006-2952(97)00480-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Busulfan--analogs & derivatives<br/>Buthionine Sulfoximine--therapeutic use<br/>Drug Synergism<br/>Gene Transfer Techniques<br/>Glioma--drug therapy<br/>Glutathione--metabolism<br/>Humans<br/>Prohibitins<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Tumor Cells, Cultured